Clinical Trial

Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This Study is a Phase 2 Study to Evaluate Efficacy, Safety, and Tolerability of HM15275 for 36 Weeks in Obese or Overweight Subjects Without Diabetes Mellitus.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-26; most recent amendment 2026-04-06.
Status change: Recruiting → Active, Not Recruiting 2026-04-06
Status change: Not Yet Recruiting → Recruiting 2025-12-04
Trial Details
NCT Number NCT07205900
Lead Sponsor Hanmi Pharmaceutical Company Limited
Conditions Obese, Obesity
Enrollment 267 participants
Start Date 2025-12-02
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-08